Showing results (301-310 of 400) with videos related to
Sort By:
Pageof 40
Journal of Virology|November 27, 2004
Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virusMiguel Islas-Ohlmayer, Angela Padgett-Thomas, Rana Domiati-Saad, et al.Medicine|May 11, 2017
A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project - a 2-year follow-up studyCristóbal Colón, J Victor Alvarez, Cristina Castaño, et al.Osteoarthritis and Cartilage|July 3, 2007
International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in Autologous Chondrocyte Implantation (ACI) and microfractureM P J van den Borne, N J H Raijmakers, J Vanlauwe, et al.Human Molecular Genetics|November 6, 2002
Molecular mechanisms of autosomal recessive hypercholesterolemiaKenneth R Wilund, Ming Yi, Filomena Campagna, et al.Journal of Virology|November 12, 2005
Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylationBangdong L Wei, Vivek K Arora, Alexa Raney, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|October 20, 2005
[Characterization of premature ventricular contraction initiating ventricular fibrillation]F Sacher, J Victor, M Hocini, et al.Journal of Virology|March 8, 2013
HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacityMorgane Rolland, Siriphan Manocheewa, J Victor Swain, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2012
Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspectiveJohannes R Streffer, Igor D Grachev, Cheryl Fitzer-Attas, et al.The Journal of Antimicrobial Chemotherapy|March 23, 2016
A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challengesMartina Kovarova, Michael D Swanson, Rosa I Sanchez, et al.Cerebrovascular Diseases (Basel, Switzerland)|October 31, 2002
Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trialJulien Bogousslavsky, Stephen J Victor, Eliseo O Salinas, et al.Pageof 40